Ianalumab plus Eltrombopag in Immune Thrombocytopenia
Ianalumab plus eltrombopag led to a longer time to treatment failure than placebo plus eltrombopag. (Funded by Novartis; VAYHIT2 ClinicalTrials.gov number, NCT05653219.).
Authors
- Nichola Cooper (ORCID: https://orcid.org/0000-0002-9845-8292)
- Thomas Stauch (ORCID: https://orcid.org/0000-0002-1622-4901)
- Patrick Urban (ORCID: https://orcid.org/0000-0002-5370-199X)
- Tatsunori Goto (ORCID: https://orcid.org/0000-0002-0314-9498)
- Masaki Iino (ORCID: https://orcid.org/0000-0002-3471-0890)
- Azizan Sharif
- Theera Ruchutrakool (ORCID: https://orcid.org/0000-0001-5717-515X)
- Judith Fronczek (ORCID: https://orcid.org/0000-0002-6159-9374)
- Waleed Ghanima (ORCID: https://orcid.org/0000-0003-2225-6165)
- Elena Rossi (ORCID: https://orcid.org/0000-0001-9152-435X)
- Marc Michel (ORCID: https://orcid.org/0000-0002-9822-7400)
- Libor Červínek
- Uttam Kumar Nath (ORCID: https://orcid.org/0000-0001-7762-803X)
- Roger E. G. Schutgens (ORCID: https://orcid.org/0000-0002-2762-6033)
- Hanny T. Al-Samkari (ORCID: https://orcid.org/0000-0001-6175-1383)
- Adam C. Cuker (ORCID: https://orcid.org/0000-0002-3595-5697)
- Thomas Zander (ORCID: https://orcid.org/0000-0002-4266-6818)
- Jae‐Ho Yoon (ORCID: https://orcid.org/0000-0002-2145-9131)
- Lien Deleu
- Ming Hou (ORCID: https://orcid.org/0000-0001-6362-0483)
- Lei Zhang (ORCID: https://orcid.org/0000-0001-7769-7377)
- Jing Sun (ORCID: https://orcid.org/0000-0002-5130-4835)
- Hung Chang (ORCID: https://orcid.org/0000-0001-8451-0304)
- Matthew Foster
- Francesco Zaja
- Marine Weill
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Novartis (Switzerland) (CH)
- Siriraj Hospital (TH)
- Chang Gung University (TW)
- University of Oslo (NO)
- Utrecht University (NL)
- Université Paris-Est Créteil (FR)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Mahidol University (TH)
- Paris-Est Sup (FR)
- Sultanah Aminah Hospital (MY)
- Agostino Gemelli University Polyclinic (IT)
- University Medical Center Utrecht (NL)
- Chang Gung Memorial Hospital (TW)
- Massachusetts General Hospital (US)
- Düsseldorf University Hospital (DE)
- Integrated Oncology (United States) (US)
- University Hospital Brno (CZ)
- Nanfang Hospital (CN)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- Jena University Hospital (DE)
- AZ Delta (BE)
- Institute of Hematology & Blood Diseases Hospital (CN)
- Centre for Inflammation Research (GB)
- St. Paul's Hospital (KR)
- University Hospital Cologne (DE)
- Østfold Hospital Trust (NO)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Qilu Hospital of Shandong University (CN)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- Yamanashi Prefectural Central Hospital (JP)
- All India Institute of Medical Sciences Rishikesh (IN)
- Heinrich Heine University Düsseldorf (DE)
- Southern Medical University (CN)
- University of Pennsylvania (US)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1056/nejmoa2515168
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00